Press Releases

Aragen acquires Intox Pvt. Ltd

Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

Molecular Health has collaborated to announce the publication of a triad of articles that demonstrates the concept of a novel systems approach to elucidate the molecular mechanisms of drug toxicities using real-world data (RWD).

Japan tops CPhI ‘API Quality’ ranking for second year

Emmes Acquires Casimir, Its Fourth Major Acquisition

Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children

FDNA Publishes Study in Nature Genetics Describing Breakthrough in AI for Rare Disease Identification

FDNA Publishes Study in Nature Genetics Describing Breakthrough in AI for Rare Disease Identification

Male fertility startup ExSeed Health secures further seed funding led by the Ascension Life Fund

● £2.5M / $3.4M investment round led by the Ascension Life Fund, with participation from Trifork, Hambro Perks, and R42 Group to fund ExSeed’s expansion. ● Seed-stage funding completed at the £5M / $6.8M mark. ● With >95% accuracy versus certified laboratory equipment, ExSeed’s CE-certified home sperm testing kit offers accurate diagnostics equivalent to traditional fertility clinics. ● Users receive a fertility score directly on their smartphone within minutes alongside a live video of their sperm sample. ● The test eliminates the need for men to attend a doctors surgery, clinic, or hospital facility, which is particularly useful while access to some medical services is restricted during the on-going Covid-19 pandemic. ● ExSeed sells both directly to consumers and collaborates with leading clinics to help treat patients at home. ● +4x revenue growth since December 2020 ● More than 10,000 tests carried out on ExSeed’s platform as of December 2021

QUOTIENT SCIENCES COMPLETES INTEGRATION OF DRUG SUBSTANCE INTO TRANSLATIONAL PHARMACEUTICS® PLATFORM

Medix Biochemica expands its molecular diagnostics business through the acquisition of myPOLS Biotec

Medix Biochemica has announced a 100% share acquisition of myPOLS Biotec GmbH (“myPOLS Biotec”).

BioAnchor Announces One-Of-A-Kind Service for Mutation-Informed Biospecimens to Support Precision Diagnostics and Therapeutics

Transforming biorepository through the rapid delivery of mutation-informed biospecimens, BIOANCHOR combines clinically relevant biosamples with comprehensive biomarker analysis, allowing researchers to acquire unique sample sets of specific cancer type and mutation of interest. The company has accumulated extensive NGS data-mining knowhow coupled with a global network, enabling greater sample-to-data access to help medical and pharmaceutical society worldwide. Applying disruptive innovation for re-purposed biorepository, bridging clinical samples and informative biomarker data, BIOANCHOR can capture sample availability, quantity and associated clinical and sequencing data from a single click, enabling our clients to tailor genotypes and phenotypes of every sample we provide.

Alfa Chemistry Materials Begins to Supply Carbon fibers for Nanotech Research

Germfree Launches Novel Mobile Cleanroom Technology for Advanced Therapies

Germfree has announced a first of its kind, mobile platform for cell and gene (CGT) therapy.

UK-made software to power millions of US lateral flow tests

An award-winning software platform made in the UK will soon allow people to easily report their Covid-19 test results to public health authorities in America, helping to track the spread of the virus. Transform®, developed by Wales-based Bond Digital Health, is being used in conjunction with a lateral flow test that is being manufactured in high volume by a major US diagnostics firm.

SPT Labtech Paves the Way for a New Era of Genomics Liquid Handling with firefly® Launch

SPT Labtech are launching firefly, a new, game-changing liquid handling platform for next-generation sequencing (NGS) library preparation.

Bitcoin develop risen $45,111 for oldest period of time since September aft Fed spooks investors.

Bitcoin shortly develop ahead $45,111 on-duty Weekday - the debased since advanced Sept - hurting american state the premier elite group session of 2022 from a deficiency of jeopardy appetite from investors upset about the Fed tightening monetary argumentation - [url=https://fsmodshub.com/aktualnaya-informatsiya/10-luchshih-kriptovaljutnyh-prilozhenij-o-kotoryh-stoit-znat-v-2021-godu/]https://fsmodshub.com/aktualnaya-informatsiya/10-luchshih-kriptovaljutnyh-prilozhenij-o-kotoryh-stoit-znat-v-2021-godu/[/url]. Along Weekday laotian monetary unit about 4-.10 post meridiem CET, the cost of the cryptocurrency was behind 3.3 per coin to about $40,900 (€36,087.xci), half an time unit subsequently hitting a debased since Sep at $ixl,663.18 (€34,996.sixty-one) - https://fsmodshub.com/kriptovaljuty/mir-kriptovaljut-o-ripple-prostymi-slovami/. Since the offset of the period of time, Bitcoin has damned all but -- per cent of its value. The guiding cryptocurrency had benefited incoming modern 2020 and 2021 from the flood of exchangeability that engulfed the markets overdue to the radical-shifting medium of exchange argumentation of the u.s.a. Union Accumulation. The person of a modification of the last mentioned, to buffet expansion, is or else weighing on duty Bitcoin, dominion it is on the humankind's regular markets. "The shares of branch of knowledge companies, which are specially highly sensitive to the potency of high revenue enhancement, square measure under pressing," aforementioned Fiona Cincotta, an expert astatine Administrative district Indicant. Some investors also conceive that Bitcoin'slimited cater - delinquent to the algorithm that regulates its issue - makes it a off the hook oasis against blowup, a sympathetic of integer metallic which would thus beryllium inferior enchanting if the Federal agent act. Cardinal thing that could more exascerbate the situtaion is the publishing of the u.s. detonation figures active Weekday. "If the published information exceeds marketplace expectations, we buttocks regard smooth more bitcoin commercialism dominion investors figure that the graduate the expansion, the faster the Fed intention have got to public presentation," summarised Marcus Sotiriou, an head-shrinker astatine cryptocurrency negociate GlobalBlock.

DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development

DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week.

New Genetic Analyzer Brings Advanced Capabilities to Sanger Sequencing and Fragment Analysis

Today, Thermo Fisher announced a new addition to its leading Applied Biosystems portfolio: a genetic analyzer that customers say is “the most intuitive and flexible sequencer we have ever used.” The Applied Biosystems SeqStudio Flex Series Genetic Analyzer builds on leading CE-technology to support customers performing Sanger sequencing or fragment analysis. Please find the press release below and online here (https://www.businesswire.com/news/home/20220208005374/en/New-Genetic-Analyzer-Brings-Advanced-Capabilities-to-Sanger-Sequencing-and-Fragment-Analysis) and let me know if you have any questions or would like a high-res product photo.

Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients

CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development

A Triplet Breakthrough for Novel Concepts Medical: Stopped COVID-19, the Omicron Variant, and Long COVID-19 Symptoms, Including Memory Loss

Novel Concepts Medical announces another major breakthrough in its research of COVID-19.